Transgenic expression of just four defined transcription factors (c-Myc, Klf4, Oct4 and Sox2) is sufficient to reprogram somatic cells to a pluripotent state [1] [2] [3] [4] . The resulting induced pluripotent stem (iPS) cells resemble embryonic stem cells in their properties and potential to differentiate into a spectrum of adult cell types. Current reprogramming strategies involve retroviral 1 , lentiviral 5 , adenoviral 6 and plasmid 7 transfection to deliver reprogramming factor transgenes. Although the latter two methods are transient and minimize the potential for insertion mutagenesis, they are currently limited by diminished reprogramming efficiencies. piggyBac (PB) transposition is host-factor independent, and has recently been demonstrated to be functional in various human and mouse cell lines [8] [9] [10] [11] . The PB transposon/transposase system requires only the inverted terminal repeats flanking a transgene and transient expression of the transposase enzyme to catalyse insertion or excision events
Transgenic expression of just four defined transcription factors (c-Myc, Klf4, Oct4 and Sox2) is sufficient to reprogram somatic cells to a pluripotent state [1] [2] [3] [4] . The resulting induced pluripotent stem (iPS) cells resemble embryonic stem cells in their properties and potential to differentiate into a spectrum of adult cell types. Current reprogramming strategies involve retroviral 1 , lentiviral 5 , adenoviral 6 and plasmid 7 transfection to deliver reprogramming factor transgenes. Although the latter two methods are transient and minimize the potential for insertion mutagenesis, they are currently limited by diminished reprogramming efficiencies. piggyBac (PB) transposition is host-factor independent, and has recently been demonstrated to be functional in various human and mouse cell lines [8] [9] [10] [11] . The PB transposon/transposase system requires only the inverted terminal repeats flanking a transgene and transient expression of the transposase enzyme to catalyse insertion or excision events 12 . Here we demonstrate successful and efficient reprogramming of murine and human embryonic fibroblasts using doxycycline-inducible transcription factors delivered by PB transposition 13 . Stable iPS cells thus generated express characteristic pluripotency markers and succeed in a series of rigorous differentiation assays. By taking advantage of the natural propensity of the PB system for seamless excision 12 , we show that the individual PB insertions can be removed from established iPS cell lines, providing an invaluable tool for discovery. In addition, we have demonstrated the traceless removal of reprogramming factors joined with viral 2A sequences 14 delivered by a single transposon from murine iPS lines. We anticipate that the unique properties of this virus-independent simplification of iPS cell production will accelerate this field further towards full exploration of the reprogramming process and future cell-based therapies.
To explore the utility of PB as a vector for somatic cell reprogramming, it was necessary to achieve temporal expression control and transgene silencing, as PB transposons are not purposefully subjected to the same natural silencing process that diminishes retroviral (and less extensively lentiviral) expression 15 . The genes for the four mouse factors (c-Myc, Klf4, Oct4 and Sox2) 1 were transferred into the PB-TET transposon plasmid (hereafter called PB-TET-mFx; Fig. 1a ) under the transcriptional control of the tetO 2 tetracycline/doxycycline inducible promoter 16 . All were linked to bgeo (a fusion of b-galactosidase and the neomycin resistant gene) through an IRES sequence to allow monitoring the tightness of doxycycline regulation and later demonstration of the reprogrammed cells' capacity for exogenous-factor-independent maintenance. The reverse tetracycline transactivator (rtTA) protein was provided by parental mouse embryonic fibroblasts (rtTA-MEFs) established from 15.5 days post coitum (d.p.c.) ROSA26 rtTA-IRES-GFP knock-in 17 transgenic embryos. rtTA-MEFs were transfected with circular PB-TET-mFx plasmid DNA 'cocktails' in conjunction with a PB transposase expression plasmid 11 . From the time of transfection onwards, fibroblasts were maintained in doxycycline-containing embryonic stem (ES) cell culture conditions without passage. Mouse fibroblasts underwent ES-cell-like colony formation, which resulted in the derivation of self-renewing cell lines displaying key characteristics of reprogramming ( Supplementary Fig. 1 ).
Colonies produced from rtTA-MEFs with PB-TET-mFx cocktails were scored on the basis of morphology, with early foci formation noted on day 6-8 and colonies forming around day 8-10. These were mostly ES-cell-like ( Supplementary Fig. 1a ), whereas a handful displayed diverse morphologies (data not shown). Adjusting the doxycycline concentration above or below the standard of 1.5 mg ml 21 resulted in subtle declines (150 ng ml
21
) or drastic decreases (15 ng ml 21 or 15 mg ml
) in colony numbers ( Supplementary Fig. 1b ), supporting the notion that factor expression level affects reprogramming rates. In the absence of doxycycline, no reprogramming was noted, nor were any cells found positive for alkaline phosphatase staining (data not shown).
Forty-eight PB-TET-mFx-induced colonies were picked from fibroblast induction fields and passaged on inactivated fibroblast feeder layers. Surviving clones were maintained in doxycycline during establishment, until found to be doxycycline independent in replicate wells. Doxycycline independence occurred as early as day 12 for 3 lines (4D, 4E, 6C), and was achieved by most clones by day 24 (7 out of 39 5 18% on day 15; 21 out of 39 5 54% on day 19; 31 out of 39 5 80% on day 21; 33 out of 39 5 86% on day 23). During establishment, cultures which had not yet achieved autonomous maintenance of reprogramming rapidly flattened and returned to a fibroblast-like state on doxycycline withdrawal ( Supplementary Fig. 2a, b) as observed in a prior report 5 . Doxycycline independence was sustained for at least an additional 18 passages, with no apparent disturbance of growth characteristics compared to replica cultures maintained in 1.5 mg ml 21 doxycycline. Doubling time and morphology of PB-TET clones were indistinguishable from those of R1 mouse ES cells 18 (data not shown). Stable reprogramming by exogenous factor expression results in the sequential activation of ES cell markers 3, 5, 19 . On day 16 (p2-3, where p indicates passage) the seven doxycycline-independent lines passed the alkaline phosphatase staining criterion (Fig. 1b) . These clones tested positive on day 20-22 for the cell-surface marker SSEA1 and nuclear-localized Nanog protein (Fig. 1b) . Semi-quantitative reverse transcription polymerase chain reaction (RT-PCR) revealed the expression of ES cell pluripotency markers [20] [21] [22] , such as Dax1, Eras, Fbxo, Foxd3, Nanog, Rex1 and Zfp296 ( Supplementary  Fig. 2c ). Using 39 untranslated region (UTR)-specific reverse primers (Supplementary Table 1 ), the endogenous counterparts of the four mFx transgenes were also shown to be active (Fig. 1c) .
PB-TET-reprogrammed clones were screened for LacZ expression to determine general transgene activity in the presence and absence of doxycycline (Fig. 1d ). RT-PCR, which allows further distinction of individual transgene activity, revealed variable trace expression levels of some transgenes in the uninduced (dox2) state (Fig. 1c) . Oct4 transgene expression could be detected in 1B and to a lesser extent in 3B, and c-Myc was maintained minimally in both 1B and 6C. For clones 1B and 3D Sox2 expression could be detected, whereas Klf4 appeared silent in all lines except for 1B. Note that RT-PCR detection of c-Myc, Klf4, Oct4 and Sox2 (mFx) transcripts reflects average expression levels for each cell population, and does not expose mosaic expression patterns (as revealed in Fig. 1d ).
Genomic Southern blot analysis was used to determine transgene copy number in selected doxycycline-independent mouse PB-TET lines ( Supplementary Fig. 3a ). The average estimated PB transposon copy number was 9, although co-migrating bands which may obscure the exact total could not be ruled out. Line 3D contains only five transposon insertions. As all four PB-TET-mFx transgenes are represented in 3D (Fig. 1c) , three of the four factors are sufficient in single copy for reprogramming.
Through additional transient transposase expression, we exploited the 'cut' step of transposition to remove the transgenes after complete reprogramming. For clone 1B, a broad range was observed in the mobilization rate for each transposon (Supplementary Figs 3b and 4); transposon 8 was excised only once (1 out of 38 5 2.5%) whereas transposon 9 was excised 11 times (11 out of 38 5 29%). Such high variability suggests that the excision frequency is integration-sitedependent. To simplify complete transgene removal we inserted the MKOS sequence (c-Myc, Klf4, Oct4 and Sox2 ORFs linked with 2A peptide sequences 14 ) into PB-TET (Fig. 2a ). Similar to four-factor reprogramming, induction of rtTA-MEFs with PB-TET-MKOS in the presence of doxycycline yielded colonies after 10-14 days. Out of 48 iPS-cell-like colonies, characterized by pluripotency marker expression and diagnostic Southern analysis (not shown), two single-copy cell lines, designated as scB1 and scC5, were established. Both lines maintained tight regulation of the MKOS reprogramming factors through indirect measurement of the LacZ reporter ( Supplementary Fig. 5 ). Splinkerette PCR 11 determined that PB inserted into the first intron of the Myo1d gene (chromosome 11) in scB1, and into an intragenic region of chromosome 16 in scC5 (Fig. 2b) . The insertion events were confirmed by locus-specific genomic PCR (Fig. 2d) . For both scB1 and scC5, transient PB transposase expression led to the removal of the linked reprogramming factors in .2% of the exposed cells as estimated by the ratio of LacZnegative sublines in the presence of doxycycline ( Supplementary  Fig. 5 ). Sequence analysis across the original insertion sites revealed that in 10 out of 11 subclones the original transposon integration site was reverted to wild type (Fig. 2c) . Complete loss of the PB-TET-MKOS transposon was further confirmed by locus-and transgenespecific genomic PCR revealing subclones which were negative for both genome-transposon junction and internal transposon-specific PCRs (Fig. 2d) . Even after the exogenous factors were removed, the endogenous pluripotency genes remained actively expressed (Fig. 2e) .
Pluripotency of PB-reprogrammed cell lines (1B, 3D, 6C, scB1 and scC5) was demonstrated by their contribution to chimaera development (Fig. 3a and Supplementary Table 2 ). Embryos were dissected between 10.5 d.p.c. and 15.5 d.p.c. and scored for GFP fluorescence, indicating contribution of reprogrammed ROSA26-rtTA-IRES-GFP parental MEFs. To reveal chimaeric contribution at the cellular level in tissues representative of the three germ layers we treated recipient dams with doxycycline 20 h before dissection, and then LacZ stained and sectioned embryos ( Fig. 3b and Supplementary Table 2) . Notably, for cell line 1B, many embryos demonstrated high-level chimaeric contribution despite low-level residual factor expression (Fig. 1c, d) , suggesting a threshold that permits differentiation of these cells in the embryonic environment. Pluripotency was stringently confirmed by the production of completely iPS-cell-derived 13.5 d.p.c. embryos (Fig. 3c ) via tetraploid embryo complementation assay 18 , including germ cell formation detected by Vasa expression 23 in the genital ridge (Fig. 3c) . Germ cell formation from iPS cells was also detected in genital ridges of standard diploid chimaeric embryos (Supplementary Fig. 6a ). Teratomas containing derivatives from all three embryonic germ layers are additional proof that these cells are pluripotent and able to differentiate to complex tissues ( Supplementary  Fig. 6b ). The chimaeric contribution of iPS cells to postnatal animals (Fig. 3d) is a clear testament to PB transposon-assisted complete reprogramming of fibroblasts to iPS cells (PB-iPS) with the capability of building functional adult tissues. We successfully used a PB-CAG-rtTA transposon together with PB-TET-mFx for doxycycline-regulated reprogramming of normal human embryonic fibroblasts. Colonies induced via transposition were picked between day 14 and day 28. Four out of five alkalinephosphatase-positive clones became doxycycline independent 1 week after isolation. Factor expression in the uninduced state was not detectable by LacZ staining (Supplementary Fig. 7a ) and only trace amounts of transcription were detected in colonies by semiquantitative RT-PCR (Supplementary Fig. 7b) . Expression of the endogenous forms of the inducer genes, however, reached levels characteristic of human ES cells ( Supplementary Fig. 7b ) along with characteristic pluripotency marker genes ( Supplementary Fig. 7c ) including nuclear-localized NANOG (Supplementary Fig. 8 ). Spontaneous differentiation after bFGF withdrawal from the medium gave rise to cystic embryoid bodies and to various differentiated cell types, including AFP (endoderm), aSMA and vWF (mesoderm), or bIII tubulin and GFAP (ectoderm) positive cells ( Supplementary Fig. 9 ). In accordance to an earlier report 24 , our observations indicate that mouse factors effectively reprogram human cells, underlining the functional conservation of these transcription factors between the two species.
Diploid chimaeras from three mouse iPS cell lines (1B, 6C and 3D) were used to derive secondary MEFs, tracking the iPS-cell-derived component (secondary fibroblast (2uF)/1B, 2uF/6C and 2uF/3D) by GFP expression (Figs 3a and 4) . Doxycycline treatment had a marked effect on 2uF/1B and 2uF/6C, which initiated early signs of reprogramming within 2 days, including cellular aggregation (Supplementary Movie). Proliferation also increased markedly, (Fig. 4 and Supplementary  Fig. 10a ) as initial contribution (10-18% on day 0) reached 90% by day 10. These physical changes were reflected at the molecular level by the activation of alkaline phosphatase (not shown) and SSEA1. The latter showed very rapid activation-detected as early as day 2, expressed by nearly 50% of 2uF/1B and 2uF/6C cells on day 4 and greater than 80% on day 8 ( Fig. 4 and Supplementary Fig. 10b ). Nanog activation occurred four days earlier (by day 9) in 2uF/1B than in 2uF/6C ( Supplementary Fig. S11 ), highlighting clonal variation and flexibility in the reprogramming process. Overall, PB-iPS-cell-derived fibroblasts displayed a much more rapid initial response to reprogramming factor induction than that previously reported for the doxycycline-inducible lentivirus system 25 , which may reflect a high level of instability for lentivirus-inserted transgene expression. Single-cell sorting of 2uF/6C cells into 96-well plates revealed that 56 of 192 single cells (29%) were capable of forming colonies. Thirty-nine out of forty-four (89%) established single-cell clones evaluated for Nanog expression were found positive on day 13 of induction. In contrast, line 2uF/3D was inefficient at secondary iPS cell production, as few doxycycline-induced colonies formed and expression of alkaline phosphatase and SSEA1 was delayed (not shown). The PB-TET-Oct4 transgene was noticeably less active in 2uF/3D as compared to 2uF/1B and 2uF/6C ( Supplementary  Fig. 10c ), signifying the need for a sufficient level of Oct4 expression even in secondary iPS cell induction.
Successful transposon-based reprogramming of fibroblasts to iPS cells represents a significant advance in current methods of transgene delivery. First, PB transposition permits technical simplification and improved accessibility of reprogramming methodology by making use of effortless plasmid DNA preparation and commercial transfection products for delivery. This eliminates the need for specialized biohazard containment facilities or the production of high-titre, limited-lifetime viral stocks 26 . Second, the range of somatic cell types that could be used for reprogramming is not limited by a decreased susceptibility to viral infection 26 . Third, PB-mediated delivery will allow the option of xeno-free production of human iPS cells contrary to current viral production protocols that use xenobiotic conditions. Finally, accurate transgene removal through transposase expression has been demonstrated in various cell lines 8, 11, 12, [27] [28] [29] . We have harnessed this potential and show here that the reprogramming factors can be removed without a trace from iPS cells once exogenous expression becomes dispensable. These four key characteristics of PB transgenesis mark important advances towards achieving clinically acceptable methods of deriving reprogrammed cells. Complementary, secondary fibroblasts or alternative secondary cell types with a combinatorial removal of proven reprogramming transgene insertions may provide an enormously powerful tool for high-throughput screening to explore further the mechanisms that have roles in the reprogramming process.
METHODS SUMMARY
PB expression vectors were generated using standard cloning procedures, whereas reprogramming factors were shuttled from retroviral sources using Gateway cloning (Invitrogen). Plasmid DNA for fibroblast transfection was prepared using a QIAprep Spin Miniprep Kit (Qiagen).
MEFs were isolated from 15. (HEFs) and transfected with PB-mFx transposon vectors and PB transposase expression plasmid 24 h later. For PB-TET-mFx transfections, expression was induced with 1.5 mg ml 21 doxycycline the following day. Forty-eight hours after transfection, cells were fed with fresh ES media daily without passage. The resulting colonies were picked on day 10-12. iPS clones were maintained on inactivated feeders, or gelatin-coated dishes.
LacZ staining was performed overnight on 0.25% glutaraldehyde-fixed cells. Alkaline phosphatase staining was done according to the manufacturer's specifications (Vector Labs). RT-PCR used cDNA prepared with the QuantiTect Reverse Transcription Kit (Qiagen). Southern blotting was carried out using standard methods and DIG-labelled probes for immunodetection (Roche). Immunostaining was performed on cells grown and fixed on chambered slides (Nunc) or 4-well dishes. Flow cytometry used live cells stained with SSEA1.
Mouse PB-TET clones were grown in the absence of doxycycline for at least three passages before aggregation with diploid or tetraploid Hsd:ICR(CD-1) or diploid C57BL/6 host embryos 30 . The prenatal embryos were dissected, scored for GFP and then further processed to perform immunohistochemistry or to derive secondary MEFs. Embryos prepared for LacZ staining and sectioning were treated with doxycycline in utero 20 h before dissection. Teratoma formation using PB-TET clones was performed as previously described 1 . Differentiation of human iPS was spontaneous on Matrigel following plating of embyroid bodies formed in AggreWell (SCI) dishes.
Full Methods and any associated references are available in the online version of the paper at www.nature.com/nature. Fluorescence-activated cell sorting (FACS) analysis establishing the dynamics of SSEA1 activation in 2uF/1B and 2uF/6C cell lines. The inset shows colony formation as early as day 5. On day 6 of reprogramming gene induction, the cultures were also passed by standard trypsinization and analysed in parallel to eliminate the negative effect of cell overgrowth.
